DEF 14A Filing

Company

Alzamend Neuro, Inc.

Filed

February 26, 2026

Period of Report

April 17, 2026

Accession Number

0001214659-26-002583

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →